Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2012.44.4.235
Full Text
Open PDFAbstract
Available in full text
Date
December 31, 2012
Authors
Publisher
Korean Cancer Association